Search DubaiPRNetwork.com

Home >> Healthcare & Medicine

Sanofi introduces innovative therapy to help address high unmet medical needs of patients with moderate to severe Atopic Dermatitis in the UAE

Sanofi introduces innovative therapy to help address high unmet medical needs of patients with moderate to severe Atopic Dermatitis in the UAE

Sunday, March 11, 2018/ Editor -  

Share

Home >> Healthcare & Medicine
  • UAE is among the first countries in the world to introduce the first targeted biologics
  • The incidence of atopic dermatitis has increased by 2- to 3-fold during the past decades in industrialized countries 
Dubai, UAE, 11 March 2018 –   Under the patronage of the Emirates Dermatology Society, Sanofi today announced the launch of an innovative therapy, that is seen to significantly help adults with moderate-to-severe atopic dermatitis (AD). After receiving a fast-track approval by the Ministry of Health & Prevention, UAE is one of the first few countries in the world to make the therapy available to patients. 
 
“Launching healthcare innovations in the UAE is high on the agenda of the Ministry of Health & Prevention, and we have taken significant steps in the past years to accelerate availability of innovations and breakthrough that improve people’s life and enhance their happiness. We are indeed driven by the vision of our beloved country leaders who want people living in our beautiful country to enjoy highest standards of life,” said His Excellency Dr. Amin Al Amiri,  Asst. Undersecretary for Public Health Policy and License Sector in UAE Ministry of Health & Prevention. 
 
Atopic dermatitis, a form of eczema, is a chronic inflammatory disease with symptoms often appearing as a rash on the skin. , , ,  It is caused, in part, by an underlying inflammation in the body that is believed to be driven by an overactive immune system. Moderate-to-severe atopic dermatitis is characterized by rashes often covering much of the body, and can include intense, persistent itching and skin dryness, cracking, redness, crusting, and oozing. ,  Itch is one of the most difficult symptoms for patients and can be severely debilitating.7 In addition, they experience impaired quality of life, including disrupted sleep, and increased anxiety and depression symptoms along with their disease. 
 
“People with moderate-to-severe atopic dermatitis can experience unbearable symptoms. Most of them endure uncontrollable itch and bleeding lesions. So, to say that this condition negatively impacts their quality of life is an understatement,” said Dr. Anwar Al Hammadi, Consultant and Head of Dermatology at Dubai Health Authority and President of Emirates Dermatology Society. “Patients struggle to effectively control their disease with the treatment options currently available.”
 
The new therapy  introduced is jointly developed by Sanofi and Regeneron under a global collaboration agreement. It is a first-in-class biologic medicine approved by the European Commission (EC) to treat adults with moderate-to-severe atopic dermatitis (AD) who are candidates for systemic therapy.  The EC approval of the medicine was based on data from the global LIBERTY AD clinical trial program that included approximately 2,800 adults living with this serious disease.      It has demonstrated a significant reduction in the signs and symptoms of the disease and improvement in quality of life. 
 
“As physicians, we welcome the timely access to this important new medication to help provide patients relief from this severely debilitating condition. As members of the UAE society, we all have a vital role to play towards raising more awareness; and hence, creating better understanding of what people with the condition go through,” added Dr. Al Hammadi.
 
Attendees at the press conference launch had the unique opportunity to experience the impact of atopic dermatitis through an art installation that captured an emotional journey through testimonials, real feelings and stories of people living with the condition. 
 
The announcement comes ahead of the medical launch of the innovative therapy for healthcare professionals on 9 March. It is expected to be attended by leading dermatologists in the country, along with global and regional experts.
 
“At Sanofi, it remains a key priority for us to bring first to the country innovative treatments, and to make sure that the most number of people to have access to them. The efforts of the UAE Ministry of Health to accelerate availability of new innovative treatments for the patients in the UAE is, indeed, remarkable,” said Jean Paul Scheuer, Country Chair and General Manager for Sanofi Gulf. The introduction of this therapy is an important milestone for people living with moderate-to-severe atopic dermatitis in UAE. 

Previous in Healthcare & Medicine

Next in Healthcare & Medicine


Home >> Healthcare & Medicine Section

Latest Press Release

Astrophysicists Measure Precise Rotation Pattern of Sun-like Stars for the First ...

Huawei Deepens Cooperation with Duisburg to Transform Germany's Industrial Hear ...

IYNC and the UAE Discuss the Way Forward for Global Nuclear Energy at IAEA Gener ...

High-octane inaugural Socca Football World Cup kicks off on September 23 in Lisb ...

Eberhard & Co. Scafograf 100 For Elegant Lady

The Mummies of Dubai Give Their Kids a Preppy Style Makeover

75 percent more speed and 58 percent more efficiency in Huawei's upcoming Mate 2 ...

du Wins Smart Cities Award at the Telecoms World Middle East 2018

Turkish Airlines reached the highest monthly Load Factor in August with 85.6% LF ...

O Boticário Opens in Dubai its First Amphora Store outside Brazil Come Join ...

Dubai Parks and Resorts Celebrates Saudi National Day

Gulf Centre for Aviation Studies hosts development course for students

FOREO To Attend TFWA: the World's Largest Travel Retail Show

Etihad Airways Deepens Ties Between Uae and Saudi Arabia to Mark National Day

Ericsson showcased SMME innovation at ITU Telecom World 2018

DigiCert, Gemalto and ISARA Partner to Ensure a Secure Future for the Internet o ...

Ministry of Human Resources and Emiratisation, Huawei and Honor launch ICT Compe ...

School children wish their favourite Unimoni Asia Cup 2018 teams good luck

Huawei MEC Solution Wins "The Best Edge Computing Technology for 5G Evoluti ...

Emirati graduate from CUD invents device to help asthma patients breathe clean a ...